Hippel James: insider trades.
Hippel James reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Hippel James
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BIO-TECHNE Corp (TECH) | Officer · CFO | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-15 | BIO-TECHNE Corp | M | 9,779 | $0 | 174,493 | Form 4 |
| 2026-08-15 | BIO-TECHNE Corp | F | 4,310 | $72.4 | 170,183 | Form 4 |
| 2026-07-29 | BIO-TECHNE Corp | F | 51,024 | $72.03 | 164,714 | Form 4 |
| 2026-07-29 | BIO-TECHNE Corp | M | 62,068 | $47.6 | 215,738 | Form 4 |
Questions
What stock did Hippel James buy or sell?
Hippel James reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Hippel James the same person as other filers with this name?
This page covers SEC CIK 1603594 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hippel-james-1603594.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.